Additional Resources

F

ADDITIONAL RESOURCES

Downloadable resources

Watch Stories of Meningitis Survivors

Meet Rayna, Katelyn, and Lauren, real survivors who are sharing their experience and how it taught them the importance of getting vaccinated against MenB.

Choose a video
actor portrayal of daughter doing homework at kitchen counter after recovering from meningococcal group B disease (MenB)
Get more helpful information about MenB at the following links

These websites are neither owned nor controlled by Pfizer. Pfizer does not endorse and is not responsible for the content or services of these sites.

find TRUMENBA® near you

Find TRUMENBA near you

arrowUse my current location Find it!Oops! Please enter a valid ZIP code
TRU NextDose reminder program
TRUMENBA offers a vaccine reminder program

Sign up for the YourNextDose reminder program to help ensure your teen or young adult gets all recommended doses.

Get reminders
IMPORTANT SAFETY INFORMATION
  • Trumenba should not be given to anyone with a history of a severe allergic reaction to any component of Trumenba
  • Some individuals with weakened immune systems may have a reduced immune response
  • Persons with certain complement deficiencies and persons receiving treatments such as Soliris® (eculizumab), are at increased risk for invasive disease caused by Neisseria meningitidis group B even with receipt of vaccination with Trumenba
  • Vaccination with Trumenba may not protect all vaccine recipients against N meningitidis group B infections
  • Fainting can occur in association with administration of injectable vaccines, including Trumenba
  • The most common adverse reactions in adolescents and young adults were pain at injection site, fatigue, headache, and muscle pain
  • Data are not available on the safety and effectiveness of using Trumenba and other meningococcal group B vaccines interchangeably to complete the vaccination series
  • Tell your health care provider if you are pregnant, or plan to become pregnant
  • Ask your health care provider about the risks and benefits of Trumenba. Only a health care provider can decide if Trumenba is right for you or your child
INDICATION
  • Trumenba is a vaccine indicated for individuals 10 through 25 years of age for active immunization to prevent invasive disease caused by Neisseria meningitidis group B

Patients should always ask their doctors for medical advice about adverse events.

You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit www.vaers.hhs.gov or call 1-800-822-7967.

This site is intended only for U.S. residents. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only and is not intended to replace discussions with a healthcare provider.
Back to top